Cornerstone pharmaceuticals strengthens scientific advisory board with the appointment of distinguished scholar jason locasale, ph.d.

Cranbury, n.j., july 06, 2022 (globe newswire) -- cornerstone pharmaceuticals, inc. (“cornerstone” or the “company”), a company focused on rare cancer therapeutics and formerly known as rafael pharmaceuticals, today announced the appointment of jason locasale, ph.d., as a member of the company's scientific advisory board. dr. locasale is a highly respected scholar and brings to cornerstone deep expertise in cancer metabolism, metabolomics, nutrition and the metabolic interface of epigenetics.
RFL Ratings Summary
RFL Quant Ranking